CHINA PHARMA HOLDINGS, INC. Long-term Construction Loan, Noncurrent
CHINA PHARMA HOLDINGS, INC. (CPHI) had Long-term Construction Loan, Noncurrent of $1.98 million as of 2020-06-30, per its 10-Q filed 2020-08-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConstructionLoanNoncurrent · last filed 2021-03-26
- 2020-06-30: Long-term Construction Loan, Noncurrent $1.98M.
- 2020-03-31: Long-term Construction Loan, Noncurrent $2.12M.
- 2019-12-31: Long-term Construction Loan, Noncurrent $2.15M.
- 2019-09-30: Long-term Construction Loan, Noncurrent $2.12M.
| Period end | Long-term Construction Loan, Noncurrent |
|---|---|
| 2020-06-30 | $1.98M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $2.12M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $2.15M 10-K · filed 2021-03-26 |
| 2019-09-30 | $2.12M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $4.22M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $4.47M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $4.36M 10-K · filed 2020-03-30 |
| 2018-09-30 | $4.37M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $6.80M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $7.17M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $6.92M 10-K · filed 2019-03-28 |
| 2017-09-30 | $6.88M 10-Q · filed 2017-11-14 |
| 2016-12-31 | $8.64M 10-K · filed 2018-04-02 |
| 2016-09-30 | $9.00M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $10.78M 10-Q · filed 2016-11-14 |
| 2013-09-30 | $6.52M 10-Q · filed 2013-11-14 |
| 2012-12-31 | $0.00 10-Q · filed 2013-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |